Monsanto : MON

All MON Articles

218 Articles

Chris Lange | Jan 5, 2017 at 1:10 PM EST

3 of Thursday’s Biggest Earnings Reports

The Trump rally has helped push the broad markets to new highs, and 24/7 Wall St. has put together a…

Chris Lange | Jan 3, 2017 at 12:35 PM EST

4 Major Earnings That Could Prop Up the Trump Rally

The Trump rally, as many are calling it, helped push the markets to these highs but it still has to…

Lee Jackson | Oct 16, 2016 at 10:05 AM EDT

Insider Buying Slows as Earnings Season Heats Up: Lands’ End, Monsanto, AZZ and More

While insider buying is slowing, it won’t stop, and you can bet that after earnings are over and the presidential…

Chris Lange | Oct 5, 2016 at 10:20 AM EDT

Monsanto Posts Mixed Q4 Results Ahead of Bayer Merger

Monsanto reported mixed fiscal fourth-quarter financial results before the markets opened on Wednesday.

Chris Lange | Oct 4, 2016 at 10:50 AM EDT

What to Look for in Monsanto Earnings

Monsanto is scheduled to release its fiscal fourth-quarter earnings report before the markets open on Wednesday.

Chris Lange | Oct 2, 2016 at 10:20 AM EDT

Top 5 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Micron Technology, Monsanto and some of the others notable companies reporting…

Jon C. Ogg | Sep 26, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AmSurg, Invesco, Monsanto, NetApp, Twitter, Ericsson, Pentair and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include AmSurg, Invesco, Monsanto, NetApp, Twitter, Ericsson and Pentair.

Jon C. Ogg | Sep 15, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Apple, AT&T, Autodesk, Bluebird Bio, Monsanto, Sarepta and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apple, AT&T, Autodesk, Bluebird Bio, Monsanto and Sarepta…

Paul Ausick | Sep 14, 2016 at 9:05 AM EDT

Bayer Stumps Up $66 Billion to Acquire Monsanto

One of the most talked about deals of the year has been the acquisition of Monsanto by German chemical giant…

Paul Ausick | Aug 31, 2016 at 4:31 PM EDT

Where’s Mine?

The U.S. Securities and Exchange Commission (SEC) on Wednesday said that 33 whistleblowers have received payments exceeding $100 million since…

Lee Jackson | Aug 29, 2016 at 8:35 AM EDT

Jefferies Top Stocks to Buy Offer Solid Dividend Yields

These four top stocks to buy have outstanding value characteristics and solid dividend yields. They make sense for balanced portfolios…

Jon C. Ogg | Aug 8, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First…

Paul Ausick | Jun 29, 2016 at 9:01 AM EDT

Monsanto Earnings Soft in Tough Ag Market

Monsanto Co. (NYSE: MON) reported fiscal third quarter 2016 results before markets opened Wednesday morning. The fertilizer and seed maker…

Chris Lange | Jun 28, 2016 at 3:20 PM EDT

What to Expect From Monsanto Earnings

Monsanto Co. (NYSE: MON) is set to report fiscal third-quarter financial results before the markets open on Wednesday. The consensus…

Chris Lange | Jun 26, 2016 at 9:40 AM EDT

Top 5 Earnings To Look For In The Coming Week

24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week.…

1 2 3 4 … 15

Monsanto : MON

All MON Articles

3 of Thursday’s Biggest Earnings Reports

4 Major Earnings That Could Prop Up the Trump Rally

Insider Buying Slows as Earnings Season Heats Up: Lands’ End, Monsanto, AZZ and More

Monsanto Posts Mixed Q4 Results Ahead of Bayer Merger

What to Look for in Monsanto Earnings

Top 5 Earnings for the Week Ahead

Top Analyst Upgrades and Downgrades: AmSurg, Invesco, Monsanto, NetApp, Twitter, Ericsson, Pentair and More

Top Analyst Upgrades and Downgrades: Apple, AT&T, Autodesk, Bluebird Bio, Monsanto, Sarepta and More

Bayer Stumps Up $66 Billion to Acquire Monsanto

Where’s Mine?

Jefferies Top Stocks to Buy Offer Solid Dividend Yields

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

Monsanto Earnings Soft in Tough Ag Market

What to Expect From Monsanto Earnings

Top 5 Earnings To Look For In The Coming Week

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Monsanto : MON

All MON Articles

3 of Thursday’s Biggest Earnings Reports

4 Major Earnings That Could Prop Up the Trump Rally

Insider Buying Slows as Earnings Season Heats Up: Lands’ End, Monsanto, AZZ and More

Monsanto Posts Mixed Q4 Results Ahead of Bayer Merger

What to Look for in Monsanto Earnings

Top 5 Earnings for the Week Ahead

Top Analyst Upgrades and Downgrades: AmSurg, Invesco, Monsanto, NetApp, Twitter, Ericsson, Pentair and More

Top Analyst Upgrades and Downgrades: Apple, AT&T, Autodesk, Bluebird Bio, Monsanto, Sarepta and More

Bayer Stumps Up $66 Billion to Acquire Monsanto

Where’s Mine?

Jefferies Top Stocks to Buy Offer Solid Dividend Yields

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

Monsanto Earnings Soft in Tough Ag Market

What to Expect From Monsanto Earnings

Top 5 Earnings To Look For In The Coming Week

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026